Siltuximab: Anti-Human IL-6 Therapeutic Antibody
Siltuximab is a chimeric monoclonal antibody binding to interleukin-6. It's been investigated for the treatment of metastatic renal cell cancer, prostate cancer, and Castleman's disease.
v7.0. We're a human-curated search engine and would love your feedback.
Siltuximab: Anti-Human IL-6 Therapeutic Antibody is live in our index. Now claim the top position. Featured sites are pinned above all standard results on the homepage, in their category, and across their target keywords. Rank is determined by remaining duration: the more years you hold, the higher you appear. Choose 1 year or more to secure the #1 position in Biomedicine, or choose 18 years to secure the #1 position across all of Viesearch.
This is how this site will appear in search results with the Premium Featured plan.
Siltuximab is a chimeric monoclonal antibody binding to interleukin-6. It's been investigated for the treatment of metastatic renal cell cancer, prostate cancer, and Castleman's disease.